Establishment Labs (NASDAQ:ESTA) Given Overweight Rating at Stephens

Stephens restated their overweight rating on shares of Establishment Labs (NASDAQ:ESTA) in a research report report published on Thursday morning,Benzinga reports. Stephens currently has a $52.00 price objective on the stock.

Establishment Labs Price Performance

Establishment Labs stock opened at $42.69 on Thursday. The company has a 50-day moving average price of $37.37 and a 200 day moving average price of $41.33. The stock has a market cap of $1.20 billion, a P/E ratio of -16.55 and a beta of 1.12. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. Establishment Labs has a 12-month low of $28.16 and a 12-month high of $60.12.

Establishment Labs (NASDAQ:ESTA) last posted its earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The firm had revenue of $44.51 million for the quarter, compared to analyst estimates of $44.45 million. Sell-side analysts anticipate that Establishment Labs will post -2.41 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Quarry LP acquired a new stake in Establishment Labs in the fourth quarter valued at approximately $27,000. R Squared Ltd acquired a new stake in Establishment Labs in the fourth quarter valued at $36,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Establishment Labs in the 3rd quarter valued at about $127,000. KLP Kapitalforvaltning AS purchased a new stake in Establishment Labs during the fourth quarter worth approximately $161,000. Finally, Hood River Capital Management LLC increased its stake in Establishment Labs by 236.4% in the fourth quarter. Hood River Capital Management LLC now owns 5,920 shares of the company’s stock valued at $273,000 after purchasing an additional 4,160 shares during the last quarter. 72.91% of the stock is owned by institutional investors and hedge funds.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.